

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 4.91333774 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.91333774 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.87755228 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.65340146 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.53644328 |
| 6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.45574582 |
| 7 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.28363856 |
| 8 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.25895067 |
| 9 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.23597437 |
| 10 | negative T cell selection (GO:0043383) | 4.16258817 |
| 11 | negative thymic T cell selection (GO:0045060) | 4.12276511 |
| 12 | response to interleukin-15 (GO:0070672) | 3.80121389 |
| 13 | cellular response to interleukin-15 (GO:0071350) | 3.62571005 |
| 14 | T cell migration (GO:0072678) | 3.58651112 |
| 15 | leukocyte aggregation (GO:0070486) | 3.44679062 |
| 16 | regulation of gamma-delta T cell activation (GO:0046643) | 3.44522809 |
| 17 | tolerance induction (GO:0002507) | 3.41187078 |
| 18 | type I interferon signaling pathway (GO:0060337) | 3.40911841 |
| 19 | cellular response to type I interferon (GO:0071357) | 3.40911841 |
| 20 | response to type I interferon (GO:0034340) | 3.38262081 |
| 21 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.36601746 |
| 22 | NIK/NF-kappaB signaling (GO:0038061) | 3.36159809 |
| 23 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.34636133 |
| 24 | response to muramyl dipeptide (GO:0032495) | 3.31712595 |
| 25 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.29391269 |
| 26 | positive T cell selection (GO:0043368) | 3.28405193 |
| 27 | modulation by symbiont of host immune response (GO:0052553) | 3.28067742 |
| 28 | positive regulation by symbiont of host defense response (GO:0052509) | 3.28067742 |
| 29 | modulation by symbiont of host defense response (GO:0052031) | 3.28067742 |
| 30 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.28067742 |
| 31 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.28067742 |
| 32 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.28067742 |
| 33 | B cell receptor signaling pathway (GO:0050853) | 3.26809411 |
| 34 | positive thymic T cell selection (GO:0045059) | 3.25657426 |
| 35 | thymic T cell selection (GO:0045061) | 3.24126833 |
| 36 | T cell selection (GO:0045058) | 3.24028444 |
| 37 | negative regulation of T cell mediated immunity (GO:0002710) | 3.18084335 |
| 38 | myeloid dendritic cell differentiation (GO:0043011) | 3.17906999 |
| 39 | regulation of T cell tolerance induction (GO:0002664) | 3.13891653 |
| 40 | hypotonic response (GO:0006971) | 3.00991100 |
| 41 | negative regulation of interleukin-12 production (GO:0032695) | 2.98248409 |
| 42 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.94055265 |
| 43 | hemidesmosome assembly (GO:0031581) | 2.92462734 |
| 44 | detection of other organism (GO:0098543) | 2.92380797 |
| 45 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.91245959 |
| 46 | myeloid dendritic cell activation (GO:0001773) | 2.90383846 |
| 47 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.89824943 |
| 48 | positive regulation of macrophage differentiation (GO:0045651) | 2.89403231 |
| 49 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.85500202 |
| 50 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.84051555 |
| 51 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.84010641 |
| 52 | interferon-gamma production (GO:0032609) | 2.83462432 |
| 53 | regulation of necroptotic process (GO:0060544) | 2.82948320 |
| 54 | germinal center formation (GO:0002467) | 2.82662803 |
| 55 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.81113507 |
| 56 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.80282973 |
| 57 | neutrophil activation involved in immune response (GO:0002283) | 2.79094712 |
| 58 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.78576612 |
| 59 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.77443377 |
| 60 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.77443377 |
| 61 | macrophage activation involved in immune response (GO:0002281) | 2.77164997 |
| 62 | hepatocyte apoptotic process (GO:0097284) | 2.76254110 |
| 63 | detection of bacterium (GO:0016045) | 2.74052498 |
| 64 | cellular extravasation (GO:0045123) | 2.73538929 |
| 65 | regulation of B cell differentiation (GO:0045577) | 2.73093355 |
| 66 | positive regulation of tolerance induction (GO:0002645) | 2.72534644 |
| 67 | * regulation of fibroblast apoptotic process (GO:2000269) | 2.72515494 |
| 68 | regulation of tolerance induction (GO:0002643) | 2.72341799 |
| 69 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.72312942 |
| 70 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.72241065 |
| 71 | B cell homeostasis (GO:0001782) | 2.71414379 |
| 72 | positive regulation of B cell differentiation (GO:0045579) | 2.68262107 |
| 73 | T cell receptor signaling pathway (GO:0050852) | 2.68018054 |
| 74 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.67839344 |
| 75 | positive regulation of granulocyte differentiation (GO:0030854) | 2.67500826 |
| 76 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.67240340 |
| 77 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.66497179 |
| 78 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.65472557 |
| 79 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.65180857 |
| 80 | detection of molecule of bacterial origin (GO:0032490) | 2.61921857 |
| 81 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.61573678 |
| 82 | positive regulation of interleukin-2 production (GO:0032743) | 2.61562902 |
| 83 | positive regulation of isotype switching (GO:0045830) | 2.60297062 |
| 84 | regulation of regulatory T cell differentiation (GO:0045589) | 2.59571992 |
| 85 | detection of external biotic stimulus (GO:0098581) | 2.58607435 |
| 86 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.58015292 |
| 87 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.57563499 |
| 88 | B cell proliferation (GO:0042100) | 2.57237131 |
| 89 | response to laminar fluid shear stress (GO:0034616) | 2.57089105 |
| 90 | response to peptidoglycan (GO:0032494) | 2.56104575 |
| 91 | defense response to protozoan (GO:0042832) | 2.55991468 |
| 92 | membrane raft organization (GO:0031579) | 2.55495203 |
| 93 | T cell costimulation (GO:0031295) | 2.55050763 |
| 94 | negative regulation of B cell proliferation (GO:0030889) | 2.54767507 |
| 95 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.53405996 |
| 96 | cellular response to virus (GO:0098586) | 2.52692259 |
| 97 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.51700703 |
| 98 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.51700703 |
| 99 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.51335031 |
| 100 | lymphocyte costimulation (GO:0031294) | 2.50246816 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.09848961 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.58696850 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.58275202 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.04488108 |
| 5 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.34464498 |
| 6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.33063706 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.07885845 |
| 8 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.03326269 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.96344033 |
| 10 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.94032901 |
| 11 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.85545051 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.81892872 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.79351861 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.78870540 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.75031428 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.64267514 |
| 17 | * MYB_26560356_Chip-Seq_TH2_Human | 2.55187693 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.54615286 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.48345365 |
| 20 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.43044008 |
| 21 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.42548069 |
| 22 | MAF_26560356_Chip-Seq_TH1_Human | 2.33570534 |
| 23 | MYC_22102868_ChIP-Seq_BL_Human | 2.27928421 |
| 24 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.20877163 |
| 25 | MYB_26560356_Chip-Seq_TH1_Human | 2.20556789 |
| 26 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.08578074 |
| 27 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.95837233 |
| 28 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.89772093 |
| 29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.86978934 |
| 30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.80031658 |
| 31 | UTX_26944678_Chip-Seq_JUKART_Human | 1.77999422 |
| 32 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.74971006 |
| 33 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.73448465 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.71477343 |
| 35 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.69363565 |
| 36 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.65654507 |
| 37 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.65654507 |
| 38 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.65627863 |
| 39 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.64849337 |
| 40 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.62041946 |
| 41 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.61210204 |
| 42 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.58193374 |
| 43 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.57127116 |
| 44 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.55173631 |
| 45 | MAF_26560356_Chip-Seq_TH2_Human | 1.54764610 |
| 46 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.53900233 |
| 47 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.52563886 |
| 48 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51753977 |
| 49 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.51632092 |
| 50 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.48453385 |
| 51 | SPI1_23127762_ChIP-Seq_K562_Human | 1.48151915 |
| 52 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.47644597 |
| 53 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.46947304 |
| 54 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.45964148 |
| 55 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.39643590 |
| 56 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.38283990 |
| 57 | GATA1_22025678_ChIP-Seq_K562_Human | 1.35394705 |
| 58 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.32098073 |
| 59 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.32029736 |
| 60 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.31976485 |
| 61 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.29413122 |
| 62 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.29172438 |
| 63 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.25875458 |
| 64 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.25806152 |
| 65 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.25739047 |
| 66 | GATA1_19941826_ChIP-Seq_K562_Human | 1.25359307 |
| 67 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.21565977 |
| 68 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.19851406 |
| 69 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18622444 |
| 70 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.14487668 |
| 71 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.14051257 |
| 72 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.13307375 |
| 73 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.13298352 |
| 74 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.10531327 |
| 75 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09584358 |
| 76 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.09499632 |
| 77 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.07610291 |
| 78 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.06705555 |
| 79 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05829794 |
| 80 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.04628523 |
| 81 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04129593 |
| 82 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03990992 |
| 83 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.01600152 |
| 84 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.01410287 |
| 85 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00980898 |
| 86 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.98050776 |
| 87 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.97159410 |
| 88 | GATA2_19941826_ChIP-Seq_K562_Human | 0.96559035 |
| 89 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.95846240 |
| 90 | ATF3_27146783_Chip-Seq_COLON_Human | 0.95217713 |
| 91 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 0.94210868 |
| 92 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.93914516 |
| 93 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.90312385 |
| 94 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90108230 |
| 95 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.89283667 |
| 96 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.88480585 |
| 97 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.88360741 |
| 98 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86266708 |
| 99 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.86259860 |
| 100 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85116199 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 3.47456584 |
| 2 | MP0003763_abnormal_thymus_physiology | 3.31939110 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.07516083 |
| 4 | MP0000685_abnormal_immune_system | 2.91085758 |
| 5 | MP0005671_abnormal_response_to | 2.87804679 |
| 6 | MP0003303_peritoneal_inflammation | 2.83797922 |
| 7 | MP0003300_gastrointestinal_ulcer | 2.79273631 |
| 8 | MP0003724_increased_susceptibility_to | 2.77252625 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.71361341 |
| 10 | MP0001800_abnormal_humoral_immune | 2.65997084 |
| 11 | MP0005387_immune_system_phenotype | 2.52843112 |
| 12 | MP0001790_abnormal_immune_system | 2.52843112 |
| 13 | MP0002723_abnormal_immune_serum | 2.30920189 |
| 14 | MP0009785_altered_susceptibility_to | 2.30213429 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.26460544 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.18254539 |
| 17 | MP0004947_skin_inflammation | 2.18009079 |
| 18 | MP0001819_abnormal_immune_cell | 2.14837809 |
| 19 | MP0002419_abnormal_innate_immunity | 2.12817677 |
| 20 | MP0005025_abnormal_response_to | 2.09872765 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 2.03539636 |
| 22 | MP0009333_abnormal_splenocyte_physiolog | 2.00996991 |
| 23 | MP0002405_respiratory_system_inflammati | 1.98674974 |
| 24 | MP0002398_abnormal_bone_marrow | 1.95040104 |
| 25 | MP0005451_abnormal_body_composition | 1.88837894 |
| 26 | MP0003656_abnormal_erythrocyte_physiolo | 1.85979392 |
| 27 | MP0010155_abnormal_intestine_physiology | 1.84814591 |
| 28 | MP0008260_abnormal_autophagy | 1.84617296 |
| 29 | MP0003191_abnormal_cellular_cholesterol | 1.84225852 |
| 30 | MP0000716_abnormal_immune_system | 1.78687800 |
| 31 | MP0002166_altered_tumor_susceptibility | 1.77338990 |
| 32 | MP0001533_abnormal_skeleton_physiology | 1.73155181 |
| 33 | MP0000858_altered_metastatic_potential | 1.70952840 |
| 34 | MP0003091_abnormal_cell_migration | 1.69925450 |
| 35 | MP0003566_abnormal_cell_adhesion | 1.69356463 |
| 36 | MP0002877_abnormal_melanocyte_morpholog | 1.68413657 |
| 37 | MP0005464_abnormal_platelet_physiology | 1.66532170 |
| 38 | MP0006082_CNS_inflammation | 1.65928474 |
| 39 | MP0002722_abnormal_immune_system | 1.58358706 |
| 40 | MP0000703_abnormal_thymus_morphology | 1.55769690 |
| 41 | MP0003828_pulmonary_edema | 1.54596683 |
| 42 | MP0001853_heart_inflammation | 1.54134424 |
| 43 | MP0003705_abnormal_hypodermis_morpholog | 1.53402522 |
| 44 | MP0000689_abnormal_spleen_morphology | 1.52548058 |
| 45 | MP0004510_myositis | 1.49514209 |
| 46 | MP0001845_abnormal_inflammatory_respons | 1.47583964 |
| 47 | MP0002429_abnormal_blood_cell | 1.47163435 |
| 48 | MP0008438_abnormal_cutaneous_collagen | 1.43941953 |
| 49 | MP0002006_tumorigenesis | 1.41279359 |
| 50 | MP0005310_abnormal_salivary_gland | 1.38143637 |
| 51 | MP0003453_abnormal_keratinocyte_physiol | 1.37348106 |
| 52 | MP0001851_eye_inflammation | 1.35338247 |
| 53 | MP0005023_abnormal_wound_healing | 1.33428562 |
| 54 | MP0009764_decreased_sensitivity_to | 1.33049130 |
| 55 | MP0002998_abnormal_bone_remodeling | 1.29327708 |
| 56 | MP0003448_altered_tumor_morphology | 1.27860168 |
| 57 | MP0002933_joint_inflammation | 1.25771992 |
| 58 | MP0005164_abnormal_response_to | 1.25757234 |
| 59 | MP0002396_abnormal_hematopoietic_system | 1.18350200 |
| 60 | MP0009840_abnormal_foam_cell | 1.17861503 |
| 61 | MP0000465_gastrointestinal_hemorrhage | 1.15850205 |
| 62 | MP0001873_stomach_inflammation | 1.13908798 |
| 63 | MP0002009_preneoplasia | 1.13785323 |
| 64 | MP0010352_gastrointestinal_tract_polyps | 1.12744781 |
| 65 | MP0004808_abnormal_hematopoietic_stem | 1.12460716 |
| 66 | MP0008469_abnormal_protein_level | 1.11674870 |
| 67 | MP0004883_abnormal_blood_vessel | 1.11008798 |
| 68 | MP0003045_fibrosis | 1.08386428 |
| 69 | MP0004381_abnormal_hair_follicle | 1.04919192 |
| 70 | MP0003866_abnormal_defecation | 1.02409808 |
| 71 | MP0001958_emphysema | 1.01197787 |
| 72 | MP0001216_abnormal_epidermal_layer | 0.98660295 |
| 73 | MP0002060_abnormal_skin_morphology | 0.98557518 |
| 74 | MP0003950_abnormal_plasma_membrane | 0.98340332 |
| 75 | MP0001348_abnormal_lacrimal_gland | 0.95942698 |
| 76 | MP0006054_spinal_hemorrhage | 0.90938459 |
| 77 | MP0005076_abnormal_cell_differentiation | 0.88860685 |
| 78 | MP0005621_abnormal_cell_physiology | 0.85401748 |
| 79 | MP0005390_skeleton_phenotype | 0.84841367 |
| 80 | MP0009763_increased_sensitivity_to | 0.84671154 |
| 81 | MP0000569_abnormal_digit_pigmentation | 0.84272646 |
| 82 | MP0000249_abnormal_blood_vessel | 0.84228947 |
| 83 | MP0008057_abnormal_DNA_replication | 0.82845011 |
| 84 | MP0003279_aneurysm | 0.82138252 |
| 85 | MP0000343_altered_response_to | 0.81304031 |
| 86 | MP0000490_abnormal_crypts_of | 0.80892904 |
| 87 | MP0003795_abnormal_bone_structure | 0.79510955 |
| 88 | MP0001545_abnormal_hematopoietic_system | 0.78636572 |
| 89 | MP0005397_hematopoietic_system_phenotyp | 0.78636572 |
| 90 | MP0002019_abnormal_tumor_incidence | 0.76810114 |
| 91 | MP0001849_ear_inflammation | 0.75510093 |
| 92 | MP0005275_abnormal_skin_tensile | 0.75224785 |
| 93 | MP0002138_abnormal_hepatobiliary_system | 0.74569135 |
| 94 | MP0003183_abnormal_peptide_metabolism | 0.74350341 |
| 95 | MP0002332_abnormal_exercise_endurance | 0.73105752 |
| 96 | MP0004185_abnormal_adipocyte_glucose | 0.72952002 |
| 97 | MP0000767_abnormal_smooth_muscle | 0.72362859 |
| 98 | MP0005058_abnormal_lysosome_morphology | 0.72053419 |
| 99 | MP0009278_abnormal_bone_marrow | 0.71688962 |
| 100 | MP0001542_abnormal_bone_strength | 0.70014632 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 4.27551549 |
| 2 | Abnormality of T cell number (HP:0011839) | 4.01838328 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.01357555 |
| 4 | Pustule (HP:0200039) | 3.51594317 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 3.51507033 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.40606415 |
| 7 | Myositis (HP:0100614) | 3.28804679 |
| 8 | Recurrent viral infections (HP:0004429) | 3.25188203 |
| 9 | Recurrent abscess formation (HP:0002722) | 3.18511256 |
| 10 | Abnormality of T cells (HP:0002843) | 3.15250826 |
| 11 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.12610159 |
| 12 | Orchitis (HP:0100796) | 3.08147576 |
| 13 | Milia (HP:0001056) | 3.04340916 |
| 14 | Recurrent fungal infections (HP:0002841) | 3.04283008 |
| 15 | Vasculitis (HP:0002633) | 3.03108102 |
| 16 | Mediastinal lymphadenopathy (HP:0100721) | 2.99185941 |
| 17 | Gastrointestinal infarctions (HP:0005244) | 2.96557108 |
| 18 | Abnormality of macrophages (HP:0004311) | 2.93146559 |
| 19 | Autoimmune hemolytic anemia (HP:0001890) | 2.92883809 |
| 20 | Optic neuritis (HP:0100653) | 2.84530211 |
| 21 | Retrobulbar optic neuritis (HP:0100654) | 2.84530211 |
| 22 | Stomatitis (HP:0010280) | 2.79864557 |
| 23 | Gastrointestinal stroma tumor (HP:0100723) | 2.77691997 |
| 24 | Recurrent bronchitis (HP:0002837) | 2.75415365 |
| 25 | Subacute progressive viral hepatitis (HP:0006572) | 2.73821057 |
| 26 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.72062282 |
| 27 | Recurrent cutaneous fungal infections (HP:0011370) | 2.72062282 |
| 28 | Lymphopenia (HP:0001888) | 2.68185896 |
| 29 | Pulmonary infiltrates (HP:0002113) | 2.67921336 |
| 30 | Thick nail (HP:0001805) | 2.66838004 |
| 31 | Meningitis (HP:0001287) | 2.65173913 |
| 32 | Cellulitis (HP:0100658) | 2.61789417 |
| 33 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.58889086 |
| 34 | Recurrent skin infections (HP:0001581) | 2.57366913 |
| 35 | IgA deficiency (HP:0002720) | 2.55808825 |
| 36 | Inflammation of the large intestine (HP:0002037) | 2.52628272 |
| 37 | Spontaneous hematomas (HP:0007420) | 2.50884266 |
| 38 | Spondylolisthesis (HP:0003302) | 2.47021044 |
| 39 | Abnormality of T cell physiology (HP:0011840) | 2.46391472 |
| 40 | Increased IgM level (HP:0003496) | 2.42622356 |
| 41 | Gastrointestinal inflammation (HP:0004386) | 2.41366161 |
| 42 | Viral hepatitis (HP:0006562) | 2.40675448 |
| 43 | Keratoconjunctivitis sicca (HP:0001097) | 2.37291173 |
| 44 | Chronic diarrhea (HP:0002028) | 2.35925923 |
| 45 | Leukocytosis (HP:0001974) | 2.35623553 |
| 46 | Agammaglobulinemia (HP:0004432) | 2.35539675 |
| 47 | Encephalitis (HP:0002383) | 2.34552790 |
| 48 | Gingivitis (HP:0000230) | 2.33917952 |
| 49 | IgG deficiency (HP:0004315) | 2.32868886 |
| 50 | Granulocytopenia (HP:0001913) | 2.30883623 |
| 51 | Verrucae (HP:0200043) | 2.30178683 |
| 52 | Papilloma (HP:0012740) | 2.30178683 |
| 53 | Atrophic scars (HP:0001075) | 2.28865476 |
| 54 | Onycholysis (HP:0001806) | 2.26661752 |
| 55 | Fatigue (HP:0012378) | 2.26114327 |
| 56 | Interstitial pulmonary disease (HP:0006530) | 2.24873572 |
| 57 | Eosinophilia (HP:0001880) | 2.24583822 |
| 58 | Urticaria (HP:0001025) | 2.23670282 |
| 59 | Colitis (HP:0002583) | 2.22709669 |
| 60 | Panhypogammaglobulinemia (HP:0003139) | 2.22562162 |
| 61 | Emphysema (HP:0002097) | 2.19634969 |
| 62 | Autoimmune thrombocytopenia (HP:0001973) | 2.18436727 |
| 63 | Increased IgE level (HP:0003212) | 2.16206835 |
| 64 | Chest pain (HP:0100749) | 2.16048085 |
| 65 | Severe combined immunodeficiency (HP:0004430) | 2.15694120 |
| 66 | Glomerulopathy (HP:0100820) | 2.14617922 |
| 67 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.14298620 |
| 68 | Abnormality of eosinophils (HP:0001879) | 2.13456616 |
| 69 | Keratoconjunctivitis (HP:0001096) | 2.12375042 |
| 70 | Obstructive lung disease (HP:0006536) | 2.11811098 |
| 71 | Chronic obstructive pulmonary disease (HP:0006510) | 2.11811098 |
| 72 | Osteolytic defects of the hand bones (HP:0009699) | 2.11261758 |
| 73 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.11261758 |
| 74 | Epistaxis (HP:0000421) | 2.10220963 |
| 75 | Gingival bleeding (HP:0000225) | 2.06337740 |
| 76 | Spinal cord lesions (HP:0100561) | 2.05890666 |
| 77 | Syringomyelia (HP:0003396) | 2.05890666 |
| 78 | Peritonitis (HP:0002586) | 2.04803208 |
| 79 | Skin ulcer (HP:0200042) | 2.03087530 |
| 80 | Osteomyelitis (HP:0002754) | 2.02972009 |
| 81 | Arterial tortuosity (HP:0005116) | 1.97758063 |
| 82 | Prolonged bleeding time (HP:0003010) | 1.91366981 |
| 83 | Hypergammaglobulinemia (HP:0010702) | 1.90675245 |
| 84 | Vertebral compression fractures (HP:0002953) | 1.90603773 |
| 85 | Dilatation of the ascending aorta (HP:0005111) | 1.90399285 |
| 86 | IgM deficiency (HP:0002850) | 1.88127950 |
| 87 | Hemoptysis (HP:0002105) | 1.88040036 |
| 88 | Lymphoma (HP:0002665) | 1.87418979 |
| 89 | Abnormality of nail color (HP:0100643) | 1.86850887 |
| 90 | Abnormal platelet volume (HP:0011876) | 1.86766027 |
| 91 | Premature loss of primary teeth (HP:0006323) | 1.86630491 |
| 92 | Combined immunodeficiency (HP:0005387) | 1.86490110 |
| 93 | Vascular tortuosity (HP:0004948) | 1.84462771 |
| 94 | Restrictive lung disease (HP:0002091) | 1.83019901 |
| 95 | Ridged nail (HP:0001807) | 1.82721640 |
| 96 | Slow saccadic eye movements (HP:0000514) | 1.81720362 |
| 97 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.80467040 |
| 98 | Persistence of primary teeth (HP:0006335) | 1.79862155 |
| 99 | Abnormal blistering of the skin (HP:0008066) | 1.79741518 |
| 100 | Periodontitis (HP:0000704) | 1.79584277 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 3.28995924 |
| 2 | MAP4K1 | 3.24545236 |
| 3 | MAP3K14 | 3.17412482 |
| 4 | TXK | 2.90977720 |
| 5 | ERN1 | 2.49814839 |
| 6 | IKBKE | 2.21714385 |
| 7 | RIPK4 | 2.12514916 |
| 8 | IRAK4 | 2.10378527 |
| 9 | JAK3 | 2.09019274 |
| 10 | TYK2 | 2.02571378 |
| 11 | CSK | 2.00609609 |
| 12 | MAP2K3 | 2.00270824 |
| 13 | ZAP70 | 1.99697560 |
| 14 | JAK1 | 1.99687915 |
| 15 | IRAK3 | 1.86383212 |
| 16 | MAP3K3 | 1.82662129 |
| 17 | BLK | 1.73208932 |
| 18 | TBK1 | 1.70806601 |
| 19 | MAP3K13 | 1.70515471 |
| 20 | BTK | 1.70052113 |
| 21 | TGFBR2 | 1.61651285 |
| 22 | IKBKB | 1.55776733 |
| 23 | GRK6 | 1.52891380 |
| 24 | NEK9 | 1.49180923 |
| 25 | STK10 | 1.48643208 |
| 26 | EPHB1 | 1.48155331 |
| 27 | SYK | 1.45272571 |
| 28 | TAOK2 | 1.42932253 |
| 29 | SIK3 | 1.42776350 |
| 30 | IRAK1 | 1.34624992 |
| 31 | CDK12 | 1.34610995 |
| 32 | BMPR2 | 1.34588128 |
| 33 | ITK | 1.33629483 |
| 34 | FES | 1.27179602 |
| 35 | HCK | 1.23236474 |
| 36 | FGFR4 | 1.18536838 |
| 37 | LCK | 1.17003438 |
| 38 | MAP3K10 | 1.16311671 |
| 39 | FGFR3 | 1.10495216 |
| 40 | IRAK2 | 1.07399685 |
| 41 | TAOK1 | 1.06579484 |
| 42 | MOS | 1.06077803 |
| 43 | TEC | 1.03314876 |
| 44 | CSF1R | 1.01806792 |
| 45 | PDGFRA | 1.01277521 |
| 46 | MST1R | 0.98608555 |
| 47 | LATS1 | 0.95205607 |
| 48 | PIM1 | 0.95053996 |
| 49 | LYN | 0.93276054 |
| 50 | PDGFRB | 0.91116391 |
| 51 | CAMKK2 | 0.90988672 |
| 52 | TESK2 | 0.90599892 |
| 53 | SIK2 | 0.89424735 |
| 54 | TTN | 0.89253752 |
| 55 | MAP3K1 | 0.88993599 |
| 56 | TRPM7 | 0.88738519 |
| 57 | CDC42BPA | 0.88187574 |
| 58 | MARK3 | 0.88039679 |
| 59 | MELK | 0.87562601 |
| 60 | FGR | 0.86821066 |
| 61 | MAPK11 | 0.83344947 |
| 62 | CLK1 | 0.82908082 |
| 63 | SCYL2 | 0.82261794 |
| 64 | GRK7 | 0.82170356 |
| 65 | RIPK1 | 0.82070207 |
| 66 | CDK6 | 0.81257338 |
| 67 | NME2 | 0.80616413 |
| 68 | SIK1 | 0.80403263 |
| 69 | CHUK | 0.76887496 |
| 70 | TRIB3 | 0.76574363 |
| 71 | JAK2 | 0.76516152 |
| 72 | HIPK2 | 0.76440559 |
| 73 | WNK1 | 0.75217581 |
| 74 | TAOK3 | 0.74683398 |
| 75 | CDK4 | 0.72194251 |
| 76 | SMG1 | 0.66067935 |
| 77 | KSR2 | 0.64252266 |
| 78 | PIK3CG | 0.63724685 |
| 79 | PRKD2 | 0.62558086 |
| 80 | LMTK2 | 0.60798024 |
| 81 | PTK2B | 0.56171855 |
| 82 | MAP3K2 | 0.54723655 |
| 83 | PRKCQ | 0.54408669 |
| 84 | STK4 | 0.53269560 |
| 85 | PAK4 | 0.52211112 |
| 86 | MAPKAPK2 | 0.51501793 |
| 87 | PDK1 | 0.50025052 |
| 88 | NLK | 0.49883891 |
| 89 | YES1 | 0.48149142 |
| 90 | STK38 | 0.46094330 |
| 91 | BMX | 0.46013463 |
| 92 | MAP3K8 | 0.45549308 |
| 93 | MAP3K5 | 0.44756892 |
| 94 | MAP3K11 | 0.44711736 |
| 95 | MAPK7 | 0.44629361 |
| 96 | KIT | 0.42991470 |
| 97 | SGK3 | 0.40325821 |
| 98 | BRD4 | 0.40276466 |
| 99 | PTK6 | 0.40192301 |
| 100 | EPHA2 | 0.40110487 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.70734139 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.40402196 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.25163074 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.16253227 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.14516787 |
| 6 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.09910907 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.08894091 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.06609779 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.05842498 |
| 10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.02266595 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.95106585 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.94482297 |
| 13 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.94436250 |
| 14 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.85762032 |
| 15 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.83513526 |
| 16 | Malaria_Homo sapiens_hsa05144 | 1.82797028 |
| 17 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.81454512 |
| 18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.67272776 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.65124810 |
| 20 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.63422378 |
| 21 | Influenza A_Homo sapiens_hsa05164 | 1.61481556 |
| 22 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.57621132 |
| 23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.57542963 |
| 24 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.55537676 |
| 25 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.52623660 |
| 26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.52419094 |
| 27 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.51595202 |
| 28 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.51585779 |
| 29 | Hepatitis B_Homo sapiens_hsa05161 | 1.50190058 |
| 30 | Viral myocarditis_Homo sapiens_hsa05416 | 1.50129497 |
| 31 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.46837542 |
| 32 | Tuberculosis_Homo sapiens_hsa05152 | 1.40849295 |
| 33 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.39990486 |
| 34 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.39939858 |
| 35 | Apoptosis_Homo sapiens_hsa04210 | 1.39071875 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.32627931 |
| 37 | Shigellosis_Homo sapiens_hsa05131 | 1.31882202 |
| 38 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.26477295 |
| 39 | Hepatitis C_Homo sapiens_hsa05160 | 1.22334008 |
| 40 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.20765504 |
| 41 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.17336958 |
| 42 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.15530038 |
| 43 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.15015219 |
| 44 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.14446770 |
| 45 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.13671614 |
| 46 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.13051289 |
| 47 | Legionellosis_Homo sapiens_hsa05134 | 1.11106623 |
| 48 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.11027666 |
| 49 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.06428000 |
| 50 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.03356430 |
| 51 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.01448199 |
| 52 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.01359650 |
| 53 | HTLV-I infection_Homo sapiens_hsa05166 | 0.99564657 |
| 54 | Asthma_Homo sapiens_hsa05310 | 0.99107819 |
| 55 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.97770043 |
| 56 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.91106049 |
| 57 | Other glycan degradation_Homo sapiens_hsa00511 | 0.90920717 |
| 58 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.90912085 |
| 59 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.90537703 |
| 60 | Pertussis_Homo sapiens_hsa05133 | 0.90322540 |
| 61 | Platelet activation_Homo sapiens_hsa04611 | 0.87984642 |
| 62 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.87236294 |
| 63 | Prostate cancer_Homo sapiens_hsa05215 | 0.83892236 |
| 64 | Bladder cancer_Homo sapiens_hsa05219 | 0.83691795 |
| 65 | Focal adhesion_Homo sapiens_hsa04510 | 0.83340747 |
| 66 | Endometrial cancer_Homo sapiens_hsa05213 | 0.81613695 |
| 67 | Amoebiasis_Homo sapiens_hsa05146 | 0.81196371 |
| 68 | Salmonella infection_Homo sapiens_hsa05132 | 0.80975726 |
| 69 | Colorectal cancer_Homo sapiens_hsa05210 | 0.80239588 |
| 70 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.77609158 |
| 71 | Endocytosis_Homo sapiens_hsa04144 | 0.75415191 |
| 72 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.74057667 |
| 73 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.73477603 |
| 74 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.68275245 |
| 75 | Phagosome_Homo sapiens_hsa04145 | 0.66276142 |
| 76 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.66264991 |
| 77 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.65560401 |
| 78 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.65448279 |
| 79 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.64343705 |
| 80 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.63663465 |
| 81 | Glioma_Homo sapiens_hsa05214 | 0.63516446 |
| 82 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.62573276 |
| 83 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60540113 |
| 84 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.59529728 |
| 85 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.58550725 |
| 86 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57548106 |
| 87 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.53873120 |
| 88 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.53288407 |
| 89 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.53055743 |
| 90 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.52769923 |
| 91 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51936050 |
| 92 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.49668811 |
| 93 | Pathways in cancer_Homo sapiens_hsa05200 | 0.49536369 |
| 94 | Lysosome_Homo sapiens_hsa04142 | 0.47836040 |
| 95 | Insulin resistance_Homo sapiens_hsa04931 | 0.47254023 |
| 96 | Thyroid cancer_Homo sapiens_hsa05216 | 0.47068379 |
| 97 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.45886311 |
| 98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.44558117 |
| 99 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.44002092 |
| 100 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.42269713 |

